ICGI

Molecular classification is crucial for prognostication, also in patients with advanced stages of endometrial cancer. …l-journal-of-gynecological-cancer.com/article/S1048-…

🎀 TIDLIG OPPDAGELSE AV BRYSTKREFT REDDER LIV 🎀Benytt deg av tilbudet om mammografi og vær oppmerksom på synlige forandringer i brystene. Les om brystkreft på kreftlex.no/Bryst @oslounivsykehus @kreftregisteret #mammografiprogrammet #rosasløyfe

Grateful to be included i @TheSchumacker ‘s talk on AI and automated desicions at #OsloPrivacyConference last week!

Artificial intelligence will impact every industry. At ICGI we embrace the change and use AI-powered systems to accelerate the advancements of cancer treatment. #AI #aicancer #kunstigintelligens #kreftforsknin #digitaliseringsdepartementet

Colorectal or #BowelCancer is the third most common cancer worldwide. Find out about advances in research and treatment options at the #ColorectalCancer Network meeting, co-hosted by @uclh and @Oslounivsykehus in Oxford on 30-31st March. Register now 📅 crcnetwork.net/meeting-regist…

We are proud to announce our Institute Director, Håvard E. G. Danielsen as keynote speaker at the Australasian Gastro-Intestinal Trials Group (AGITG) Scientific Meeting 2022. #AGITG22

Learning about Artificial intelligence and predicting patient outcomes from image analysis of tumours : a likely future #AGITG22

We are happy to announce that Fahri Saatcioglu and his team at @UniOslo & ICGI at @oslounivsykehus have been granted funding from @Kreftforeningen. The research on unfolded protein response in cancer cells will benefit many cancer patients. kreftforeningen.no/aktuelt/186-mi…

I fjor fikk nær 4000 norske kvinner brystkreft. Tidlig diagnostisering og store fremskritt innen behandling har ført til at overlevelsen for brystkreftpasienter har blitt mye bedre 🎀🎀 MAMMOGRAFI REDDER LIV! 🌸 Les mer om brystkreft på kreftlex.no/Bryst

Inspiration for our Sept issue cover: A clinical #decision #support system optimising #adjuvant #chemotherapy for #colorectalcancers by integrating #deeplearning and #pathological staging markers: a development and validation study thelancet.com/journals/lanon…

By leveraging a deep learning marker, 1 of 3 colorectal cancer patients with local (lymph node) metastasis may safely avoid adjuvant chemotherapy. This will greatly reduce morbidity and treatment costs. @Oslounivsykehus @OsloCancercluster @forskningsradet

Online first: A clinical #decision #support system optimising #adjuvant #chemotherapy for #colorectalcancers by integrating #deeplearning and #pathological staging markers: a development and validation study thelancet.com/journals/lanon…

@forskningsradet, @Oslounivsykehus, @OsloCancer, @DIPSASA, @UiOResearchAdm, @unioslo_mn, @domorediagnostics, @OusResearch, @SykehusVestfold #cancerresearch, #DeepLearning #AI #pathology #DoMore #DoMoreDiagnostics

@OsloCancer @InnovasjonNorge @HakonHaugli Gratulerer!

Join us at Radiumhospitalet, Oslo University Hospital, for an engaging afternoon on AI in healthcare. Please register at domore.no #forskningsraadet, #oslouniversitetssykehus, #kreftforskning

We welcome all interested in AI and Healthcare to an engaging afternoon and hope you will join us at the final DoMore! conference November 24, 2021. 13:30 - 18:00 Forskningsbygget, Radiumhopsitalet, Oslo universitetssykehus, Ullernchausseen 70. domore.no

"– DoMore! er et bunnsolid investeringscase", sier Ivar Kroghrud, partner i Norselab. Les E24s artikkel om storfondet Noreslab og teknologiinvestor Øyvind Grotmols investering i DoMore! Diagnostics nå som DoMore!-prosjektet er i sluttfasen. e24.no/teknologi/i/M3…

We are looking forward to working with Drs. Miangela M. Lacle and Lisa van der Schee in the Dutch T1 Colorectal Cancer Working Group to improve the quality of life and survival of people with early-stage colorectal cancer. #ai #deeplearning #colorectalcancer #domore

Do not forget to follow Sepp De Raedts presentation on AI in diagnostics! @nvidia @OsloCancer @OsloScienceCity @UniOslo_MED @unilabs @unioslo_mn @NORAdotAI @radforsk media-exp1.licdn.com/dms/image/C562…